Another study of Egyptian patients indicated that TGF-β1 is associated with the severity of liver disease, in which patients with hepatocellular carcinoma had significantly higher serum TGF-β1 compared to patients with liver cirrhosis and healthy subjects (Kohla et al., 2017). This evidence concerns the gene TGFB1 and hepatocellular carcinoma.